A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

Novo Nordisk Investigational Site

Los Angeles, California, United States, 90027

Novo Nordisk Investigational Site

New Haven, Connecticut, United States, 06511

Novo Nordisk Investigational Site

Jacksonville, Florida, United States, 32207

Novo Nordisk Investigational Site

Baton Rouge, Louisiana, United States, 70808

Novo Nordisk Investigational Site

Baltimore, Maryland, United States, 21287

Novo Nordisk Investigational Site

Buffalo, New York, United States, 14203

Novo Nordisk Investigational Site

Cincinnati, Ohio, United States, 45229

Novo Nordisk Investigational Site

Cincinnati, Ohio, United States, 45229

Novo Nordisk Investigational Site

Columbus, Ohio, United States, 43205

Novo Nordisk Investigational Site

Philadelphia, Pennsylvania, United States, 19104

Novo Nordisk Investigational Site

Amarillo, Texas, United States, 79106

Novo Nordisk Investigational Site

Charlottesville, Virginia, United States, 22908

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 13, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments